Clinical Perspective: Potential use of Polio Vaccine for COVID-19 Prevention
The novel coronavirus disease 2019 (COVID-19) pandemic that caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a detrimental effect on every fabric of society. Childhood poliovirus vaccination is believed to have a causative link between SARS-CoV-2 immunity. This report was aimed to explore the effect and evidence of the polio vaccine in preventing COVID-19 infection. Literature has shown that the oral polio vaccine produces broader protection against unrelated pathogens. Both the poliovirus and coronavirus belong to the same positive-strand RNA virus category, which can be eliminated by common innate immunity mechanisms. Vaccination against the poliovirus triggers an adaptive humoral immune response that raises antibodies that cross-react with SARS-CoV-2.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Author(s) shall retain the copyright of their work and grant the Journal/Publisher right for the first publication with the work simultaneously licensed under:
Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows for the copying, distribution and transmission of the work, provided the correct attribution of the original creator is stated. Adaptation and remixing are also permitted.
This broad license intends to facilitate free access to, as well as the unrestricted reuse of, original works of all types for non-commercial purposes.
The author(s) permits HH Publisher to publish this article that has not been submitted elsewhere.